Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT138903244179N1Phase 4Completed
Phase 4 trial of levothyroxine sodium in hypothyroidism and dyslipidemia, sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Change in lipid profile. Started May 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT138903244179N1.